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Introduction
Staphylococcus lugdunensis is a species of coagulase-negative 
staphylococci (CoNS), which was first described by Freney 
et al in 1988. S. lugdunensis is differentiated from other CoNS 
by its ability to produce ornithine decarboxylase and pyr-
rolidonyl arylamidase (PYR). It is commonly found on the 
human skin and is a rare contaminant in culture. Since its 
first identification, many publications have recognized its 
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BACKGROUND/PURPOSE: Infective endocarditis caused by Staphylococcus lugdunensis is a rare disease. 
Since its first description in 1988, there have only been a few reports of this disease and the causative 
organism. These publications were primarily case reports and brief case series. We conducted a literature 
review to identify the nature of the disease and its risk factors.
METHODS: We retrospectively reviewed the cases reported between 1988 and 2008 by searching the 
relevant literature using the keywords “endocarditis” and “Staphylococcus lugdunensis” in the Medline 
database. All cases included met the definition of the modified Duke criteria.
RESULTS: For the period 1988–2008, 67 cases from 27 articles were reviewed. The mean age of individuals 
was 53.9 years. Left-sided valvular endocarditis represented 52 (82.5%) of cases and native-valve endocarditis 
was evident in 48 (78.7%) of cases. A large proportion (82%) of 50 S. lugdunensis strains were susceptible to 
penicillin. Valve replacement operations were performed in 42 (66.7%) patients and the mortality rate was 
38.8%. Univariate analysis showed a higher mortality rate in patients aged more than 50 years, those 
treated before 1995, those treated with antibiotics alone, and those with growth not detected by echocar-
diography. Medical treatment alone was the independent risk factor for mortality by multivariate analysis.
CONCLUSION: S. lugdunensis endocarditis led to substantial morbidity and mortality. Detailed micro-
biological identification, echocardiography evaluation, and valve replacement may improve the clinical 
outcome of individuals with S. lugdunensis endocarditis.
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pathogenic role in the infections of multiple systems in-
cluding infective endocarditis (IE), osteomyelitis, septic 
arthritis, brain abscess, urinary tract infections and soft 
tissue infections.1–4
The first case of IE caused by S. lugdunensis was de-
scribed in 1988.5 Since then, only a few case reports and 
brief case series have been published regarding IE caused 
by S. lugdunensis. Most of these reports revealed that IE 
caused by S. lugdunensis could be very aggressive and that 
mortality was high. These characteristics of S. lugdunensis 
IE differed largely from other CoNS IE.
A 16-year-old girl without remarkable past history was 
admitted to our hospital because of right flank pain and 
fever. S. lugdunensis was isolated in two separate sets of blood 
cultures. Echocardiography showed vegetation at the mitral 
valve, therefore surgery was performed and the outcome 
was fair without complications.
To provide more insight into the clinical presentations 
and to evaluate prognostic factors associated with the 
mortality of this disease, we have extensively reviewed the 
literature including our one recent case that was treated 
successfully.
Methods
We conducted a systematic Medline review covering the 
period January 1, 1988 through to June 30, 2008. The 
search terms used were “endocarditis” and “Staphylococcus 
lugdunensis”. The searches focused on peer-reviewed arti-
cles published in English. After locating the bibliographic 
references, we retrieved the abstracts of all selected arti-
cles. Two clinicians read the abstracts and complete arti-
cles independently and, by consensus, decided upon the 
articles to be included in the study.
The retrieved articles were included in this study if the 
case reported met the modified Duke criteria of IE with 
isolates of S. lugdunensis.6 These articles must contain spe-
cific information regarding clinical, microbiological, ther-
apy and outcome variables. For each patient reported, the 
following variables were recorded: demographic data (age 
and sex), clinical data (year of diagnosis, portal of entry, 
sites and types of involved valves and initial echocardiog-
raphy findings), microbiological data (susceptibility of 
S. lugdunensis), therapy (antimicrobial treatment with or 
without surgery), and outcome (death or recovery).
Statistical analysis
Statistics Package for Social Science version 10.0 (SPSS 
Inc., Chicago, IL, USA) was used for statistical analyses. 
Mean, standard deviation, median and range were calcu-
lated for continuous variables. We used χ2 test and Fisher’s 
exact test to determine any significant differences between 
groups with categorical variables. Univariate analyses were 
conducted to determine the association between potential 
risk factors and mortality. Variables that were significant in 
the univariate analysis were included in the multiple factors 
analysis. A multiple logistic regression model was used to 
identify those variables independently associated with the 
risk for mortality. The level of significance for all statistical 
tests was p ≤ 0.05.
Results
A total of 67 cases of S. lugdunensis IE were included. In our 
comprehensive review of the literature from 1988 to 2008, 
66 cases were identified from 27 articles.5–7,28 One case 
was recently treated successfully from our hospital. All of 
the 67 cases met the modified Duke criteria. None of the 
patients were injection drug users.
Table 1 shows the overall characteristics of the cases 
reported. The mean age of cases was 53.9 years (range, 
7–82 years). Forty-one (61.2%) cases involved males and 
41 cases (61%) were older than 50 years. Forty-five (67.2%) 
cases were community-acquired with an unknown portal of 
entry. Thirty-six cases (65.5%) had co-morbidities. Native 
valve, prosthetic valve and pacemaker IE accounted for 
80.6%, 11.9% and 7.5% of cases, respectively. Antimicrobial 
susceptibility reports were available in 50 patients, of which 
82.0% (41 patients) were susceptible to penicillin. About 
87% of IE cases occurred on the left side. Of the left-side 
lesions, mitral valve, aortic valve and both represented 40.3%, 
32.8% and 11.9% of the total cases. Eight (11.9%) cases had 
multi-valvular involvement, and all multi-valvular lesions 
were on the left side. Eleven (16.4%) cases had the occurrence 
of embolization. Among 54 patients that received echocar-
diography examinations, vegetation could be detected in 42 
(77.8%) cases. Forty-six (68.7%) cases received both antimi-
crobial therapy and surgery. The overall mortality rate of 
S. lugdunensis IE was 38.8%.
Table 2 shows the comparison between the dead and 
surviving cases with S. lugdunensis IE. The mortality rates 
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for native valve endocarditis, prosthetic valve endocarditis 
and pacemaker lead endocarditis were 34.6%, 75% and 20%, 
respectively. Upon univariate analysis, variables that had 
significant association with mortality included: age greater 
than 50 years, medical treatment alone, negative echocar-
diography findings and diagnosis before 1995. In the mul-
tivariate logistic regression analysis, medical treatment 
alone was an independent risk factor for mortality (odds 
ratio = 4.79; 95% confidence interval = 1.16–19.78) (Table 3).
Discussion
S. lugdunensis was first described in 1988 by Freney et al. 
S. lugdunensis is differentiated from other CoNS by the ability 
to produce ornithine decarboxylase and PYR. S. lugdunensis 
shares some properties with S. aureus. Both may express 
clumping factor and/or a thermostable DNase and have 
the same virulence determinants.29 The colony morphol-
ogy of S. lugdunensis also resembles S. aureus and may be 
accidentally identified as S. aureus.30 Approximately 25% 
of clinical isolates of S. lugdunensis produce extracellular 
slime or glycocalyx, which plays an important role in bac-
terial colonization and interferes with the phagocytosis-
associated activities of neutrophils.
According to the published reports, the clinical pres-
entations of IE caused by CoNS were different from those 
caused by S. aureus in many ways.31–33 Although S. lugdun-
ensis is a CoNS, some reports have showed that the presen-
tation of S. lugdunensis IE was more similar to S. aureus IE 
than to IE caused by other CoNS.34–36
In our study, S. lugdunensis IE usually developed in the 
cases aged above 50 years. Most patients acquired the in-
fection in the community and the sites of entry were not 
identified. Most strains of S. lugdunensis isolated were sen-
sitive to penicillin. S. lugdunensis usually invades the left-side 
valves with mitral or aortic valve involvement. Sometimes, 
both mitral and aortic valves could be involved simultane-
ously. The majority of cases were in the native valve, and IE 
caused by other CoNS were often hospital-acquired and 
related to indwelling devices.31,33 CoNS usually invaded 
prosthetics valves37 and most CoNS were resistant to pen-
icillin.38 These were the characteristics of S. lugdunensis that 
differed from other CoNS.
In our review, 68.7% (46/67) of patients received valve 
replacement and the rate of surgery was higher than for 
Table 1. Clinical characteristic of 67 cases of Staphylococcus 
lugdunensis infective endocarditisa
Characteristics n (%)
Age (yr) 53.88 ± 19.14 (7–82)
Sex
 Male 41 (61.2)
 Female 26 (38.8)
Portal of entry
 Known 22 (32.8)
 Unknown  45 (67.2)
Comorbidity
 Yes 36 (65.5)
 No 19 (34.5)
Location
 Left-sided 58 (86.6)
  Mitral valve 27 (40.3)
  Aortic valve 22 (32.8)
  Both 8 (11.9)
 Right-sided 5 (7.5)
  Tricuspid valve 4 (6.0)
  Pulmonary valve 1 (1.5)
Pacemaker lead 4 (6.0)
Vegetations on echocardiography
 Yes  42 (77.8)
 No 12 (22.2)
Penicillin susceptibility
 Yes 41 (82.0)
 No  9 (18.0)
Embolization
 Yes 11 (16.4)
 No 56 (83.6)
Surgery
 Yes 46 (68.7)
 No 21 (31.3)
Outcome
 Recovered 41 (61.2)
 Death 26 (38.8)
Characteristics of valve
 Native valve 54 (80.6)
 Prosthetic valve 8 (11.9)
 Pacemaker lead 5 (7.5) 
aData presented as mean ± standard deviation (range) or n (%).
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other pathogens. Four series showed that rates of valve re-
placement in IE caused by all pathogens ranged from 15% to 
45%.39–42 In a study of 912 consecutive IE cases between 1990 
and 2003, significantly more patients with S. lugdunensis 
IE underwent surgery compared with those with S. aureus IE 
(70% vs. 37%); the surgical rate for S. epidermidis IE was similar 
to that for S. lugdunensis IE.2 The mortality rate of S. lugdunen-
sis IE was significantly higher than that for S. epidermidis IE.2
In one series, S. lugdunensis IE often caused valve de-
struction with abscess formation and progressed to con-
gestive heart failure rapidly.2 The antimicrobial treatment 
usually could not completely eradicate the infectious pro-
cesses in most cases. Finally, surgical interventions with 
valve replacement were often needed in most cases reported. 
Our study showed that surgery was the only independent 
risk factor for mortality.
Table 2. Comparisons between mortal and surviving cases of Staphylococcus lugdunensis infective endocarditis
Variables Total case, n Mortal case, n (%) OR (95% CI) p
Age (yr)
 ≤ 50 41 20 (48.7) 1 0.040
 > 50 26 6 (23.1) 3.18 (1.06–9.53)
Sex
 Male 41 18 (43.9) 1 0.320
 Female 26 8 (30.9) 1.76 (0.63–4.96)
Penicillin susceptible
  Yes 41 15 (36.6) 1 0.720
 No   9 4 (44.4) 0.72 (0.17–3.11)
Surgery
 Yes 46 12 (26.1) 1 0.003
 No  21 14 (66.6) 5.67 (1.85–17.38)
Location of vegetations
 Left-sided  57 24 (42.1)
  Right-sided  4 0 (0)
 Pacemaker lead  5 1 (20.0)
Type of infective valve
 Native valve 52 18 (34.6)
 Prosthetic valve  8 6 (75.0)
 Pacemaker lead  5 1 (20.0)
Valvular replacement
  Yes
  No
Source of infections
 Recognized  22 6 (27.3) 1 0.180
 Unrecognized 45 20 (44.4) 2.13 (0.71–6.46)
Vegetations on echocardiography
 Yes 42 10 (23.8) 1 0.040
 No 17 12 (70.6) 4.49 (1.16–17.27)
Diagnosis before 1995
 Yes 21 13 (62.0) 1 0.030
 No 42 13 (31.0) 3.63 (1.21–10.86)
OR = odds ratio; CI = confidence interval.
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In our review, the mortality rate associated with 
S. lugdunensis IE was 38.8%. In a previous series, the overall 
mortality of IE ranged from 18.0% to 24.6%.39–42 In a study 
of 558 patients with S. aureus endocarditis from 2003, the 
mortality rate was 22.4%.43 According to Whitener et al in 
1993, the mortality rate of CoNS IE was 16%.33 Compared 
with these results, the mortality of S. lugdunensis endocar-
ditis appeared to be higher. Further analysis should be 
performed to verify this hypothesis.
Prosthetic valve endocarditis accounted for 11.9% of 
S. lugdunensis endocarditis cases. These patients often had 
greater comorbidity because of underlying cardiac problems. 
Deterioration of clinical conditions often delayed operations 
for valve replacement, and sometimes only conservative 
treatment was suggested. Overall, pacemaker lead endo-
carditis constituted 8.2% of S. lugdunensis endocarditis cases 
and the mortality rate was 20%. Removal of the bacteria with 
antimicrobial therapy was commonly used in these patients 
and mortality was low compared with other subgroups.
Most isolates of S. lugdunensis (82%) were susceptible to 
penicillin. In studies by Auguera et al and Zinkernagel et al, 
most isolates of S. lugdunensis were susceptible to penicillin.2 
Unlike most CoNS, isolates of S. lugdunensis were also gen-
erally susceptible to multiple agents. In 2006, Hellbacher 
analyzed 39 isolates of S. lugdunensis and demonstrated that 
S. lugdunensis isolates were generally susceptible to most of 
the antibiotics currently used.30 Despite the remarkable 
susceptibility to a wide array of antimicrobial agents, med-
ical treatment alone was seldom successful and the majority 
of patients still received surgery for valve replacement.
Most microbiological laboratories do not routinely 
identify CoNS to the species level. Additionally, both 
S. lugdunensis and S. aureus could be positive in the latex ag-
glutination test because they show similar colony mor-
phology and produce clumping factor. Thus, S. lugdunensis 
might be misidentified as S. aureus in routine microbio-
logical laboratory tests. Because of the enhanced virulence 
and destructive nature of S. lugdunensis, the prompt identi-
fication of this organism to the species level is essential 
whenever it is suspected. If a very aggressive form of S. aureus 
IE is encountered, the possibility of S. lugdunensis IE should 
also be considered. There are several biochemical tests 
able to identify S. lugdunensis easily. First, S. lugdunensis re-
veals a negative result in tube coagulase tests. Further-
more, S. lugdunensis can be positively differentiated from 
other CoNS due to positive PYR reaction and positive 
ornithine decarboxylase activity.
There are some limitations in this study. The main source 
of information was cases reported in the literature. There 
is potential for significant selection bias for higher severity, 
a more complicated course and poorer outcome so that 
these cases were more likely to be published. In addition, 
individual investigator’s reports could not be standardized 
for patients’ variables and a bias might exist. Some of the 
sickest patients who might be considered surgical candidates 
were excluded from surgical options, and certain subgroups 
of a small number of cases may produce type II errors.
Although uncommon, S. lugdunensis is a very aggressive 
and destructive pathogen with a major role in IE. Exam-
ination of the limited data available would suggest surgery 
appears to be the preferred choice of treatment. In the fu-
ture, with more cases published from series reports, there 
should be sufficient cases for more detailed analysis, and 
hopefully the inherent bias of the analysis will be decreased.
References
1. Bellamy R, Barkham T. Staphylococcus lugdunensis infection sites: 
predominance of abscesses in the pelvic girdle region. Clin Infect 
Dis 2002;35:E32–4.
2. Anguera I, Del Río A, Miró JM, Matínez-Lacasa X, Marco F, 
Gumá JR, et al. Staphylococcus lugdunensis infective endocarditis: 
description of 10 cases and analysis of native valve, prosthetic 
valve, and pacemaker lead endocarditis clinical profiles. Heart 
2005;91:e10.
3. Haile DT, Hughes J, Vetter E, Kohner P, Snyder R, Patel R, et al. 
Frequency of isolation of Staphylococcus lugdunensis in consecutive 
urine cultures and relationship to urinary tract infection. J Clin 
Microbiol 2002;40:654–6.
Table 3. Multivariate analysis of risk factors for mortality 
among 67 reported cases of Staphylococcus lugdunensis infective 
endocarditis
Variables OR (95% CI) p
Medical treatment alone 4.79 (1.16–19.78) 0.02
Prosthetic valves 4.00 (0.55–29.32) 0.87
Negative echocardiography 0.84 (0.27–2.55) 0.33
 finding
Age > 50 yr 0.37 (0.10–1.42) 0.14
Diagnosis before 1995 0.23 (0.08–1.01) 0.07
OR = odds ratio; CI = confidence interval.
 483
S. lugdunensis infective endocarditis
4. Kaabia N, Scauarda D, Lena G, Drancourt M. Molecular identi-
fication of Staphylococcus lugdunensis in a patient with meningitis. 
J Clin Microbiol 2002;40:1824–5.
5. Smyth EG, Wright ED, Marples RR. New type of staphylococcal 
endocarditis. J Clin Pathol 1988;41:809–10.
6. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. 
Proposed modifications to the Duke criteria for the diagnosis of 
infective endocarditis. Clin Infect Dis 2000;30:633–8.
7. Etienne J, Pangon B, Leport C, Wolff M, Clair B, Perronne C, 
et al. Staphylococcus lugdunensis endocarditis. Lancet 1989;1:390.
8. Barker KF, O’Driscoll JC, Bhargava A. Staphylococcus lugdunensis. 
J Clin Pathol 1991;44:873–4.
9. Cormican MG, el Bouri K, Corbett-Feeney G, Flynn J, Daly K. 
Staphylococcus lugdunensis endocarditis. J Infect 1992;24:335–6.
10. Sheppard M, Jankowski S. Staphylococcus lugdunensis endocarditis. 
J Infect 1992;25:116–7.
11. Shuttleworth R, Colby WD. Staphylococcus lugdunensis endocardi-
tis. J Clin Microbiol 1992;30:1948–52.
12. Walsh B, Mounsey JP. Staphylococcus lugdenensis and endocarditis. 
J Clin Pathol 1990;43:171.
13. Kralovic SM, Melin-Aldana H, Smith KK, Linnemann CC Jr. 
Staphylococcus lugdunensis endocarditis after tooth extraction. 
Clin Infect Dis 1995;20:715–6.
14. Koh TW, Brecker SJ, Layton CA. Successful treatment of Staphy-
lococcus lugdunensis endocarditis complicated by multiple emboli: 
a case report and review of the literature. Int J Cardiol 1996;
55:193–7.
15. Bobin S, Durand-Dubief A, Bouhour D, Kirkorian G, Vandenesch 
F, Etienne J, et al. Pacemaker endocarditis due to Staphylococcus 
lugdunensis: report of two cases. Clin Infect Dis 1999;28:404–5.
16. Fervenza FC, Contreras GE, Garratt KN, Steckelberg JM. 
Staphylococcus lugdunensis endocarditis: a complication of vasec-
tomy? Mayo Clin Proc 1999;74:1227–30.
17. Polenakovik H, Herchline T, Bacheller C, Bernstein J. Staphy-
lococcus lugdunensis endocarditis after angiography. Mayo Clin Proc 
2000;75:656–7.
18. Farrag N, Lee P, Gunney R, Viagappan GM. Staphylococcus lugdunensis 
endocarditis. Postgrad Med J 2001;77:259–60.
19. Jones RM, Jackson MA, Ong C, Lofland GK. Endocarditis caused 
by Staphylococcus lugdunensis. Pediatr Infect Dis J 2002;21:265–8.
20. Renzulli A, Della Corte A, Torella M, Dialetto G, Cotrufo M. 
Mitral and aortic valve endocarditis due to Staphylococcus lugdun-
ensis. Tex Heart Inst J 2000;27:67–9.
21. Sotutu V, Carapetis J, Wilkinson J, Davis A, Curtis N. The “sur-
reptitious Staphylococcus”: Staphylococcus lugdunensis endocarditis 
in a child. Pediatr Infect Dis J 2002;21:984–6.
22. Seenivasan MH, Yu VL. Staphylococcus lugdunensis endocarditis—
the hidden peril of coagulase-negative staphylococcus in blood 
cultures. Eur J Clin Microbiol Infect Dis 2003;22:489–91.
23. Viganego F, Nazir TM, Lee CY, Hafner JP, Smith R. Staphylococcus 
lugdunensis endocarditis following lower extremity revasculariza-
tion. Int J Cardiol 2007;116:e4–6.
24. Van Hoovels L, De Munter P, Colaert J, Surmont I, Van 
Wijngaerden E, Peetermans WE, et al. Three cases of destructive 
native valve endocarditis caused by Staphylococcus lugdunensis. Eur 
J Clin Microbiol Infect Dis 2005;24:149–52.
25. Gianella S, Ulrich S, Huttner B, Speich R. Conservative manage-
ment of a brain abscess in a patient with Staphylococcus lugdunensis 
endocarditis. Eur J Clin Microbiol Infect Dis 2006;25:476–8.
26. Kourbeti IS, Alegakis DE, Roditakis GE, Samonis G. Staphylococcus 
lugdunensis early prosthetic valve endocarditis in a young HIV 
positive patient. Infection 2007;35:40–2.
27. Takahashi N, Shimada T, Ishibashi Y, Yoshitomi H, Sugamori T, 
Sakane T, et al. The pitfall of coagulase-negative staphylococci 
A case of Staphylococcus lugdunensis endocarditis. Int J Cardiol 2009;
137:e15–7.
28. Zinkernagel AS, Zinkernagel MS, Elzi MV, Genoni M, Gubler J, 
Zbinden R, et al. Significance of Staphylococcus lugdunensis 
Bacteremia: report of 28 Cases and Review of the Literature. 
Infection 2008;36:314–21.
29. Lambe DW Jr, Ferguson KP, Keplinger JL, Gemmell CG, 
Kalbfleisch JH. Pathogenicity of Staphylococcus lugdunensis, Staphy-
lococcus schleiferi, and three other coagulase-negative staphylococci 
in a mouse model and possible virulence factors. Can J Microbiol 
1990;36:455–63.
30. Hellbacher C, Tornqvist E, Soderquist B. Staphylococcus lugdunensis: 
clinical spectrum, antibiotic susceptibility, and phenotypic and 
genotypic patterns of 39 isolates. Clin Microbiol Infect 2006;12:43–9.
31. Huebner J, Goldmann DA. Coagulase-negative staphylococci: 
role as pathogens. Annu Rev Med 1999;50:223–36.
32. Fernandez Guerrero ML, Gonzalez Lopez JJ, Goyenechea A, 
Fraile J, de Gorgolas M. Endocarditis caused by Staphylococcus 
aureus: a reappraisal of the epidemiologic, clinical, and patho-
logic manifestations with analysis of factors determining out-
come. Medicine (Baltimore) 2009;88:1–22.
33. Whitener C, Caputo GM, Weitekamp MR, Karchmer AW. 
Endocarditis due to coagulase-negative staphylococci. Micro-
biologic, epidemiologic, and clinical considerations. Infect Dis 
Clin North Am 1993;7:81–96.
34. Stout RD, Li Y, Miller AR, Lambe DW Jr. Staphylococcal glycoca-
lyx activates macrophage prostaglandin E2 and interleukin 1 
production and modulates tumor necrosis factor alpha and 
nitric oxide production. Infect Immun 1994;62:4160–6.
35. Lambe DW Jr, Jeffery C, Ferguson KP, Cooper MD. Examination 
of the glycocalyx of four species of Staphylococcus by transmis-
sion electron microscopy and image analysis. Microbios 1994;78:
133–43.
36. Donvito B, Etienne J, Denoroy L, Greenland T, Benito Y, 
Vandenesch F. Synergistic hemolytic activity of Staphylococcus 
lugdunensis is mediated by three peptides encoded by a non-agr 
genetic locus. Infect Immun 1997;65:95–100.
37. von Eiff C, Proctor RA, Peters G. Coagulase-negative staphyloco-
cci. Pathogens have major role in nosocomial infections. Postgrad 
Med 2001;110:63–4, 69–70, 73–6.
484
P.Y. Liu, et al
38. Huang SY, Tang RB, Chen SJ, Chung RL. Coagulase-negative 
staphylococcal bacteremia in critically ill children: risk factors 
and antimicrobial susceptibility. J Microbiol Immunol Infect 2003;
36:51–5.
39. Chu J, Wilkins G, Williams M. Review of 65 cases of infective 
endocarditis in Dunedin Public Hospital. NZ Med J 2004;117:
U1021.
40. Ferreiros E, Nacinovich F, Casabé JH, Modenesi JC, Swieszkowski 
S, Cortes C, et al. Epidemiologic, clinical, and microbiologic 
profile of infective endocarditis in Argentina: a national survey. 
The Endocarditis Infecciosa en la Republica Argentina-2 (EIRA-2) 
Study. Am Heart J 2006;151:545–52.
41. Krcmery V, Gogová M, Ondrusová A, Buckova E, Doczeova A, 
Mrazova M, et al. Etiology and risk factors of 339 cases of infec-
tive endocarditis: report from a 10-year national prospective sur-
vey in the Slovak Republic. J Chemother 2003;15:579–83.
42. Sandre RM, Shafran SD. Infective endocarditis: review of 135 
cases over 9 years. Clin Infect Dis 1996;22:276–86.
43. Petti CA, Fowler VG Jr. Staphylococcus aureus bacteremia and 
endocarditis. Cardiol Clin 2003;21:219–33vii.
